Sep 10, 2019 / 04:55PM GMT
David Ryan Lewis - Morgan Stanley, Research Division - MD
All right, so let's go ahead and get started. My name is David Lewis, Medical Device Analyst at Morgan Stanley. It's my pleasure to have with us here a couple of members of management of iRhythm, both Kevin King, the CEO; and Matt Garrett, the CFO. We're going to dispense with any preamble, unless you want to give one.
Kevin M. King - iRhythm Technologies, Inc. - President, CEO & Director
No.
Questions and Answers:
David Ryan Lewis - Morgan Stanley, Research Division - MDStraight into Q&A. I just want to remind people, as I have all day long, just go to Morgan Stanley research disclosure website and look at fun, fancy facts about me.
Kevin, I want to start with the action from last week, frankly, which is kind of 2-part nature, equity raise and Verily collaboration. Two things I want to talk about is what does Verily do for you and why was this the right time to raise money?
Kevin M. King - iRhythm
Trustpilot
